Hint mode is switched on Switch off

Disc Medicine, ordinary share
IRON, US2546041011

Add a stock to WL
Choose all Reset all
Disc Medicine, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Disc Medicine, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. Disc Medicine develops therapeutic candidates that aim to address ...
Disc Medicine, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. Disc Medicine develops therapeutic candidates that aim to address spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Disc Medicine Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    IRON
  • Placement
    15.06.2023
  • Lock up period
    180
  • Number of papers
    22,171,161
  • Volume of raised funds
    127.2 mln USD
  • Placement share
    11.71%
  • Final placement price
    49 USD
  • Price change since placement date
    38.87%
  • By capitalization
    1,086.39 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    IRON
  • Placement
    14.06.2024
  • Lock up period
    180
  • Number of papers
    4,944,000
  • Volume of raised funds
    177.98 mln USD
  • Placement share
    16.68%
  • Final placement price
    36 USD
  • Price change since placement date
    89.02%
  • By capitalization
    1,067.04 mln USD

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

26/02/2026 Disc Medicine: Costs Associated With Exit Or Disposal Activities
17/02/2026 Disc Medicine: Regulation Fd Disclosure, Financial Statements And Exhibits
13/02/2026 Disc Medicine: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
16/01/2026 Disc Medicine, Inc. (NASDAQ:IRON) Maintains "Outperform" Rating Amidst Market Volatility
12/01/2026 Disc Medicine: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.